Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It causes muscle weakness and affects gait, balance and overall movement, as ...

Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It causes muscle weakness and affects gait, balance and overall movement, as ...

The clinical diagnosis of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) remains challenging due to heterogeneity of the diseases. The final antemortem diagnosis was incorrect ...

What is progressive supranuclear palsy (PSP), Jesse Jackson's rare illness? Jesse Jackson, a key figure in the U.S. civil rights movement, faced a long struggle with serious health issues before his ...

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share overlapping ...

In Alzheimer's disease, aggregation of Aβ precedes tau aggregation, but in primary tauopathies, the upstream instigators are shrouded in mystery. A study published May 25 in Science Advances casts ...

Researchers from the University of Melbourne have established how two diseases that present in similar ways are in fact quite different. Progressive Supranuclear palsy (PSP) and Parkinson's Disease ...

Drawing from UK Biobank data, Mass General Brigham researchers have uncovered specific health factors linked to higher or lower risk of developing progressive supranuclear palsy (PSP), a rare but ...

The recent discovery of a unique protein pattern in spinal fluid may make earlier diagnosis of progressive supranuclear palsy a reality. Researchers at the University of California San Francisco (CA, ...

Background Progressive supranuclear palsy and Parkinson's disease have characteristic clinical and neuropathologic profiles, but also share overlapping clinical features. This study aimed to analyze ...